» Authors » Giuseppe Maulucci

Giuseppe Maulucci

Explore the profile of Giuseppe Maulucci including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 83
Citations 1166
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Fard D, Testa E, Panzeri V, Rizzolio S, Bianchetti G, Napolitano V, et al.
Cell Mol Life Sci . 2023 Mar; 80(4):111. PMID: 37002363
Transmembrane semaphorins are signaling molecules, controlling axonal wiring and embryo development, which are increasingly implicated in human diseases. Semaphorin 6C (Sema6C) is a poorly understood family member and its functional...
12.
Abeltino A, Bianchetti G, Serantoni C, Riente A, De Spirito M, Maulucci G
Nutrients . 2023 Mar; 15(5). PMID: 36904199
Nutrition is a cross-cutting sector in medicine, with a huge impact on health, from cardiovascular disease to cancer. Employment of digital medicine in nutrition relies on digital twins: digital replicas...
13.
Bianchetti G, Clementi M, Sampaolese B, Serantoni C, Abeltino A, De Spirito M, et al.
Antioxidants (Basel) . 2023 Feb; 12(2). PMID: 36829896
Diabetes-induced oxidative stress induces the development of vascular complications, which are significant causes of morbidity and mortality in diabetic patients. Among these, diabetic retinopathy (DR) is often caused by functional...
14.
Zimatore G, Serantoni C, Gallotta M, Guidetti L, Maulucci G, De Spirito M
Int J Environ Res Public Health . 2023 Feb; 20(3). PMID: 36767364
During exercise with increasing intensity, the human body transforms energy with mechanisms dependent upon actual requirements. Three phases of the body's energy utilization are recognized, characterized by different metabolic processes,...
15.
Bianco D, De Maio F, Santarelli G, Palucci I, Salustri A, Bianchetti G, et al.
Antibiotics (Basel) . 2023 Jan; 12(1). PMID: 36671372
Even though Everolimus has been investigated in a phase II randomized trial as a host-directed therapy (HDT) to treat tuberculosis (TB), an oncological patient treated with Everolimus for a neuroendocrine...
16.
Teveroni E, Di Nicuolo F, Vergani E, Bruno C, Maulucci G, Bianchetti G, et al.
Int J Mol Sci . 2022 Nov; 23(21). PMID: 36361515
The non-orthotopic expression of olfactory receptors (ORs) includes the male reproductive system, and in particular spermatozoa; their active ligands could be essential to sperm chemotaxis and chemical sperm-oocyte communication. OR51E2...
17.
Bianchetti G, Rizzo G, Serantoni C, Abeltino A, Rizzi A, Tartaglione L, et al.
Int J Mol Sci . 2022 Oct; 23(19). PMID: 36232429
In this work, we will investigate if red blood cell (RBC) membrane fluidity, influenced by several hyperglycemia-induced pathways, could provide a complementary index of HbA1c to monitor the development of...
18.
Zimatore G, Gallotta M, Campanella M, Skarzynski P, Maulucci G, Serantoni C, et al.
Int J Environ Res Public Health . 2022 Oct; 19(19). PMID: 36232025
Heart rate time series are widely used to characterize physiological states and athletic performance. Among the main indicators of metabolic and physiological states, the detection of metabolic thresholds is an...
19.
Teveroni E, Di Nicuolo F, Vergani E, Bianchetti G, Bruno C, Maulucci G, et al.
Cancers (Basel) . 2022 Oct; 14(19). PMID: 36230799
(1) Background: PTTG1 sustains the EMT process and the invasiveness of several neoplasms. We previously showed the role of nuclear PTTG1 in promoting invasiveness, through its transcriptional target MMP2, in...
20.
Cavallucci V, Palucci I, Fidaleo M, Mercuri A, Masi L, Emoli V, et al.
Biomolecules . 2022 Sep; 12(9). PMID: 36139097
Intestinal bacterial communities participate in gut homeostasis and are recognized as crucial in bowel inflammation and colorectal cancer (CRC). (), a pathobiont of the oral microflora, has recently emerged as...